glp-1 obesity drug news october 21 2025 Americans Need More Information About Weight Loss Drugs Companies seek a second obesity

Cell Metab 36(6):13021319 e12 Scott Butsch W, Sulo S, Chang AT, Kim JA, Kerr KW, Williams DR et al (2025) Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study

For use in vitamin B12 deficiency associated with cobalt deficiency in cattle and sheep and for vitamin B12 deficiency associated with inadequate vitamin B12 intake or intestinal malbsorption in swine and horses.

,

This helps prevent competition with other nutrients and may improve the absorption of the supplement into your bloodstream

About this article Cite this article Pelepenko, L.E., de Oliveira, M.C., Masaro, D.A

In more recent times, lorcaserin (Belviq) was also withdrawn, due to an increased risk (albeit only 9%) of cancer [49] , which the FDA deemed as not being outweighed by the benefits of lorcaserin for any identifiable patient population